Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog)
Raf-kinase inhibitor protein has been reported to inhibit both the Raf/mitogen extracellular signal–regulated kinase/extracellular signal–regulated kinase and nuclear factor kappa-light-chain of activated B cells pathways. It has also been reported in cancers that Raf-kinase inhibitor protein behave...
Saved in:
| Main Authors: | SoHyun Lee, Stephanie Wottrich, Benjamin Bonavida |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-04-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317692253 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structural characterization of stem cell factors Oct4, Sox2, Nanog and Esrrb disordered domains, and a method to detect phospho-dependent binding partners
by: Bouguechtouli, Chafiaa, et al.
Published: (2024-04-01) -
An Oct4‐Sall4‐Nanog network controls developmental progression in the pre‐implantation mouse embryo
by: Meng How Tan, et al.
Published: (2013-01-01) -
Assessment of the Potential of CDK2 Inhibitor NU6140 to Influence the Expression of Pluripotency Markers NANOG, OCT4, and SOX2 in 2102Ep and H9 Cells
by: Ade Kallas, et al.
Published: (2014-01-01) -
Expression of the stem cell markers NANOG and SOX2 in the cervical squamous carcinogenesis
by: Koren Miha, et al.
Published: (2025-04-01) -
FLT3 inhibition upregulates OCT4/NANOG to promote maintenance and TKI resistance of FLT3-ITD+ acute myeloid leukemia
by: Qi Zhou, et al.
Published: (2025-03-01)